Skip to main content

Day: March 12, 2024

LUMIBIRD: ANNUAL RESULTS 2023

Lannion, 12/03/2024 – 17h45 ANNUAL RESULTS 2023EBITDA margin(1) of 17% (reported basis) and 18% excluding Convergent, higher than previously announced targets Last year of the transformation plan, with the modernisation and rationalisation of our industrial facilities. After 3 years of heavy investment and structuring, adjustments to expenses have been made at the end of 2023 with the closure of the Ottawa (Canada) and Leigh (UK) sites. Growth trajectory reaffirmed, with the aim of improving operational efficiency and profitabilityThe Lumibird Group, European leader in laser technologies, improved its reported EBITDA by 10% to €34.5m (+15% to €36.1m excluding the acquisition of Convergent). This performance reflects tight cost control against a backdrop of sales growth. As the Group is positioned and structured to continue to...

Continue reading

Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference

EAGLE, Idaho, March 12, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2024 Oppenheimer Healthcare MedTech & Services Conference on March 13, 2024. Lynette Walbom, Chief Financial Officer, and John Gochnour, President and Chief Operating Officer, will participate in a fireside chat that day at 10:00 a.m. Eastern Time. A live webcast of the event will be accessible on the Investor Relations section of Pennant’s website at http://investor.pennantgroup.com. About Pennant: The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 104 home health and hospice agencies and 53 senior living...

Continue reading

Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study  

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psyence Biomedical Ltd (NASDAQ:PBM) (“PBM” or “Psyence Biomed“) has received full approval from the Australian Health Research Ethics Committee (HREC) to initiate its planned Phase IIb study in Melbourne, Australia. The study will be conducted through PBM’s subsidiary, Psyence Australia (Pty) Ltd (“Psyence Australia“) and will examine the use of nature-derived psilocybin as a treatment for Adjustment Disorder due to a recent cancer diagnosis in the palliative care context. According to a news release issued...

Continue reading

Kymanox® to Consolidate Brands of Acquired Companies

Unifying Brands Highlights Extensive Offerings Kymanox Provides to the Life Science Community, Supporting Innovative Products Reaching the Patient. Morrisville, North Carolina USA,, March 12, 2024 (GLOBE NEWSWIRE) — Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the life sciences industry, announced today that the company will consolidate the brands of four recently acquired companies into the Kymanox brand. These companies include Neuma, based in King of Prussia, PA, Agilis Consulting Group, based in Cincinnati, OH, and Europe-based Anteris Helvetia and Anteris Medical. This consolidation effort will provide clearer communication of the extensive offerings and solutions provided by Kymanox, thus fostering the team’s ability to meet the complex needs of clients while continuing to provide trusted...

Continue reading

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

GRANTS, NEW MEXICO, March 12, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for a $250 million construction project to expand the Company’s current research, production and extraction processing facility located in rural Grants, New Mexico (the “Dalsem Agreement”). The proposed expansion will add 7 million square feet of manufacturing and production capabilities. The Dalsem Agreement provides that Dalsem will construct the additional facility to its specifications and build them in a modular fashion. Additionally, the Company has entered into a credit agreement with a lender for a $60 million senior debt financing to fund the expansion construction project (the “Credit Agreement”). The Credit...

Continue reading

Man Group PLC : Form 8.3 – Smith (DS) plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Smith (DS) plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position disclosure,...

Continue reading

Man Group PLC : Form 8.3 – Mondi plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Mondi plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position disclosure,...

Continue reading

Nordic American Tankers Ltd (NYSE: NAT) – Alexander Hansson buys more NAT shares

  Tuesday, March 12, 2024   Dear Shareholders and Investors,   Alexander Hansson, Non-Executive Vice Chairman of Nordic American Tankers Ltd (NAT) and son of Herbjorn Hansson, Founder, Chairman & CEO, has today bought 75,000 shares in NAT at $4,031 per share for a total sum of $302,325. Following these transactions, Monaco based Alexander Hansson privately owns 2,575,000 shares in NAT. As in the past, the Hansson family is the largest private shareholder group in the company. For contacts, please see at the end of this communication.      Sincerely, Herbjorn HanssonFounder, Chairman & CEO Nordic American Tankers Ltd.                                                           www.nat.bm        CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press release may constitute forward-looking statements....

Continue reading

Boyden Norway and ISCO Group Merge to Form Leadership Solutions Powerhouse

Market-leading brands combine sector specialisation and global reach, strengthening leadership and talent expertise for Norwegian, European and multinational clients OSLO, Norway, March 12, 2024 (GLOBE NEWSWIRE) — Boyden, a premier global leadership and talent advisory firm, is delighted to announce its merger in Norway with leading Norwegian firm ISCO Group, a pioneer in helping clients to drive growth through executive search and leadership expertise. Kjetil Haug-Nodeland Managing Partner, Boyden-ISCO commented, “On behalf of Boyden, we are very proud to announce this merger with one of the most established and admired firms in the market. There are strong indicators for consolidation in our industry and this strategic move will reshape the executive search and leadership consulting landscape. Clients need global capabilities...

Continue reading

Dassault Aviation: Total number of shares and voting rights – 08 03 24

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 63,161,449.60 euros Headquarters: 9, Rond-Point des Champs-Élysées – Marcel Dassault 75008 PARIS 712 042 456 RCS Paris Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)DateTotal number of sharesTotal number of voting rights03/08/2024 78,951,812Theoretical voting rights: 131,078,186 Exercisable voting rights: 130,834,582AttachmentTotal number of shares and voting rights – 08 03 24

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.